CDH2 and breast cancer: Additionally, the Western blot results indicated a substantial increase in expression of the mesenchymal markers N-cadherin and vimentin, accompanied by a decrease in expression of the epithelial marker E-cadherin in cells treated with MCF-7-derived exosomes (Fig. 2F), suggesting that MCF-7-derived exosomes may promote EMT in breast cancer.